Skip to content

Elecsys proBNP II 07027664190Recalls & reported problems

Roche Diagnostics GmbH · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04015630939756), received between Jul 26, 2018 and Jul 26, 2018 — classified as 1 malfunction.

The most frequently reported specific device problem is “Low Test Results” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Low Test Results1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 26, 2018Low Test Results; Low Test Results

    THE CUSTOMER RECEIVED QUESTIONABLE LOW ELECSYS PROBNP II IMMUNOASSAY RESULTS FOR ONE PATIENT FROM A COBAS E 801 MODULE. THE SERIAL NUMBER WAS REQUESTED BUT WAS NOT PROVIDED. FOR MULTIPLE SAMPLES FROM THE PATIENT, THE ELECSYS PROBNP RESULT WAS ALWAYS <5 PG/ML, BUT THE BNP RESULTS WERE BETWEEN 20-49 PG/ML. THE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE PHYSICIAN BELIEVED "THERE SHOULD BE HEART LOAD IN THE PATIENT" SINCE THE PATIENT HAS OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7722122 ↗

Other TEST,NATRIURETIC PEPTIDE devices

All TEST,NATRIURETIC PEPTIDE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page